SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-060045
Filing Date
2012-11-07
Accepted
2012-11-07 16:09:33
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v325773_10q.htm 10-Q 317411
2 EXHIBIT 31.1 v325773_ex31-1.htm EX-31.1 9137
3 EXHIBIT 31.2 v325773_ex31-2.htm EX-31.2 9252
4 EXHIBIT 32.1 v325773_ex32-1.htm EX-32.1 3850
5 EXHIBIT 32.2 v325773_ex32-2.htm EX-32.2 3902
  Complete submission text file 0001144204-12-060045.txt   2497343

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT chtp-20120930.xml EX-101.INS 245457
7 XBRL TAXONOMY EXTENSION SCHEMA chtp-20120930.xsd EX-101.SCH 28749
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE chtp-20120930_cal.xml EX-101.CAL 24746
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE chtp-20120930_def.xml EX-101.DEF 125815
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE chtp-20120930_lab.xml EX-101.LAB 231365
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chtp-20120930_pre.xml EX-101.PRE 165635
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51462 | Film No.: 121186863
SIC: 2836 Biological Products, (No Diagnostic Substances)